Key points are not available for this paper at this time.
Minimal residual disease-negative status after treatment for newly diagnosed MM is associated with long-term survival. These findings provide quantitative evidence to support the integration of MRD assessment as an end point in clinical trials of MM.
Munshi et al. (Thu,) studied this question.